Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire E Bocchini

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Blood Advances|February 22, 2024
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipientsJustin Z Amarin, Daniel E Dulek, Joshua Simmons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2023
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled TrialJennifer E Schuster, Lubna Hamdan, Daniel E Dulek, et al.
The Journal of Infectious Diseases|September 16, 2024
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza SeasonHannah Bahakel, Andrew J Spieker, Haya Hayek, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood Advances|February 22, 2024
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipientsJustin Z Amarin, Daniel E Dulek, Joshua Simmons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2023
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled TrialJennifer E Schuster, Lubna Hamdan, Daniel E Dulek, et al.
The Journal of Infectious Diseases|September 16, 2024
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza SeasonHannah Bahakel, Andrew J Spieker, Haya Hayek, et al.
Pageof 3